Quote | Longeveron Inc. (NASDAQ:LGVN)
Last: | $1.67 |
---|---|
Change Percent: | 0.0% |
Open: | $1.72 |
Close: | $1.67 |
High: | $1.7201 |
Low: | $1.6 |
Volume: | 321,374 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Longeveron Inc. (NASDAQ:LGVN)
MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024. Details for the Company’s pres...
Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has closed on its warran...
Message Board Posts | Longeveron Inc. (NASDAQ:LGVN)
Subject | By | Source | When |
---|---|---|---|
institutions loading up,nhod,ka-freaking-BOOM!!! | 81vette | investorshub | 05/09/2023 4:29:36 PM |
ZERO BORROW,just now out of shares,1st time in | 81vette | investorshub | 05/09/2023 4:06:18 PM |
5m float,short 166k shares,197Xs ave volume should push | 81vette | investorshub | 05/09/2023 2:45:28 PM |
MomentumIts now last up | Roadtojourney | investorshub | 05/08/2023 8:13:19 PM |
$LGVN Price gaining last trade up | subslover | investorshub | 05/08/2023 4:36:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Longeveron Inc. Company Name:
LGVN Stock Symbol:
NASDAQ Market:
MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing regenerative medicine...
MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024. Details for the Company’s pres...
Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has closed on its warran...